Serum GGT

Biomarker

1 paper1 finding

  • Humans1

Associations

1

Pancreatobiliary cancer

upin humans1HR 1.554

1 study
  1. Serum GGT raises the risk of pancreatobiliary cancer in humans (HR 1.554 for quartile 4 vs quartile 1, p < 0.001).

    “The adjusted hazard ratio for pancreatobiliary cancer in quartiles 2-4 compared with that in quartile 1 was 1.091, 1.223, and 1.554, respectively, demonstrating a significant upward trend (p < 0.001).”

    Humansdiabetes mellitus7.2 years

    Association between Gamma-glutamyl Transferase Levels and Pancreatobiliary Cancer Risk in Diabetes—Evidence from the National Health Insurance Cooperation Health Checkup 2009–2012

    ADA Scientific Sessions 2025 abstract13 Jun 2025

More on Pancreatobiliary cancer

Latest